Nancy M. Laing

1.5k total citations
20 papers, 1.2k citations indexed

About

Nancy M. Laing is a scholar working on Epidemiology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Nancy M. Laing has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 11 papers in Molecular Medicine and 8 papers in Pharmacology. Recurrent topics in Nancy M. Laing's work include Antibiotic Resistance in Bacteria (11 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Pneumonia and Respiratory Infections (6 papers). Nancy M. Laing is often cited by papers focused on Antibiotic Resistance in Bacteria (11 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers) and Pneumonia and Respiratory Infections (6 papers). Nancy M. Laing collaborates with scholars based in Canada and United States. Nancy M. Laing's co-authors include George G. Zhanel, James A. Karlowsky, Melanie DeCorby, Daryl J. Hoban, Jack Johnson, Tamiko Hisanaga, Ayman Noreddin, Kimberly A. Nichol, Heather J. Adam and Kim Nichol and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Nancy M. Laing

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy M. Laing Canada 15 718 446 261 246 168 20 1.2k
Melanie DeCorby Canada 16 724 1.0× 676 1.5× 147 0.6× 285 1.2× 189 1.1× 19 1.2k
Kim Nichol Canada 19 674 0.9× 756 1.7× 376 1.4× 375 1.5× 207 1.2× 33 1.5k
Funda Timurkaynak Türkiye 13 488 0.7× 481 1.1× 117 0.4× 151 0.6× 114 0.7× 26 926
L. Gualco Italy 12 470 0.7× 360 0.8× 128 0.5× 103 0.4× 124 0.7× 24 794
L. Stratchounski Russia 16 536 0.7× 609 1.4× 141 0.5× 187 0.8× 151 0.9× 25 1.2k
S. Bouchillon United States 19 623 0.9× 882 2.0× 175 0.7× 371 1.5× 250 1.5× 34 1.4k
Mark E. Jones United States 13 402 0.6× 743 1.7× 170 0.7× 210 0.9× 226 1.3× 14 1.2k
Tetsuro Muratani Japan 19 401 0.6× 370 0.8× 153 0.6× 134 0.5× 99 0.6× 56 1.0k
Hyuck Lee South Korea 18 420 0.6× 249 0.6× 233 0.9× 84 0.3× 122 0.7× 44 941
Εlias Iosifidis Greece 23 670 0.9× 792 1.8× 382 1.5× 459 1.9× 188 1.1× 82 1.5k

Countries citing papers authored by Nancy M. Laing

Since Specialization
Citations

This map shows the geographic impact of Nancy M. Laing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy M. Laing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy M. Laing more than expected).

Fields of papers citing papers by Nancy M. Laing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy M. Laing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy M. Laing. The network helps show where Nancy M. Laing may publish in the future.

Co-authorship network of co-authors of Nancy M. Laing

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy M. Laing. A scholar is included among the top collaborators of Nancy M. Laing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy M. Laing. Nancy M. Laing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Karlowsky, James A., Philippe Lagacé‐Wiens, Nancy M. Laing, et al.. (2020). Susceptibility of Clinical Isolates of Escherichia coli to Fosfomycin as Measured by Four In Vitro Testing Methods. Journal of Clinical Microbiology. 58(10). 10 indexed citations
3.
Karlowsky, James A., Philippe Lagacé‐Wiens, Heather J. Adam, et al.. (2019). In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007–2016. International Journal of Antimicrobial Agents. 54(1). 62–68. 14 indexed citations
4.
5.
Lagacé‐Wiens, Philippe, Heather J. Adam, Nancy M. Laing, et al.. (2017). Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential. Journal of Antimicrobial Chemotherapy. 72(8). 2273–2277. 27 indexed citations
6.
Adam, Heather J., et al.. (2009). In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone, against 2,440 Clinical Isolates. Antimicrobial Agents and Chemotherapy. 53(11). 4915–4920. 61 indexed citations
7.
8.
Karlowsky, James A., Nancy M. Laing, & George G. Zhanel. (2008). In Vitro Activity of OPT-80 Tested against Clinical Isolates of Toxin-Producing Clostridium difficile. Antimicrobial Agents and Chemotherapy. 52(11). 4163–4165. 51 indexed citations
9.
Zhanel, George G., Mel DeCorby, Nancy M. Laing, et al.. (2008). Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006. Antimicrobial Agents and Chemotherapy. 52(4). 1430–1437. 215 indexed citations
10.
Wierzbowski, Aleksandra, Kimberly A. Nichol, Nancy M. Laing, et al.. (2007). Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004). Journal of Antimicrobial Chemotherapy. 60(4). 733–740. 45 indexed citations
11.
Nichol, Kimberly A., et al.. (2006). Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America. International Journal of Antimicrobial Agents. 27(5). 392–396. 27 indexed citations
12.
Zhanel, George G., Tamiko Hisanaga, Nancy M. Laing, et al.. (2006). Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). International Journal of Antimicrobial Agents. 27(6). 468–475. 226 indexed citations
13.
Zhanel, George G., et al.. (2006). Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model. Journal of Antimicrobial Chemotherapy. 59(1). 144–147. 3 indexed citations
14.
15.
Karlowsky, James A., Daryl J. Hoban, Melanie DeCorby, Nancy M. Laing, & George G. Zhanel. (2006). Fluoroquinolone-Resistant Urinary Isolates of Escherichia coli from Outpatients Are Frequently Multidrug Resistant: Results from the NorthAmerican Urinary Tract Infection Collaborative Alliance-QuinoloneResistance Study. Antimicrobial Agents and Chemotherapy. 50(6). 2251–2254. 132 indexed citations
16.
Adam, Heather J., Kristen N. Schurek, Kimberly A. Nichol, et al.. (2006). Molecular Characterization of Increasing Fluoroquinolone Resistance in Streptococcus pneumoniae Isolates in Canada, 1997 to 2005. Antimicrobial Agents and Chemotherapy. 51(1). 198–207. 42 indexed citations
17.
Zhanel, George G., Tamiko Hisanaga, Nancy M. Laing, et al.. (2005). Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). International Journal of Antimicrobial Agents. 26(5). 380–388. 173 indexed citations
18.
19.
Zhanel, George G., Christel Johanson, Tamiko Hisanaga, et al.. (2004). Pharmacodynamic activity of telithromycin against macrolide-susceptible and macrolide-resistant Streptococcus pneumoniae simulating clinically achievable free serum and epithelial lining fluid concentrations. Journal of Antimicrobial Chemotherapy. 54(6). 1072–1077. 20 indexed citations
20.
Zelenitsky, Sheryl, Brent M. Booker, Nancy M. Laing, et al.. (1999). Synergy of an Investigational Glycopeptide, LY333328, with Once-Daily Gentamicin against Vancomycin-Resistant Enterococcus faecium in a Multiple-Dose, In Vitro Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy. 43(3). 592–597. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie DeCorby Breakdown of academic impact, for papers by Kim Nichol Breakdown of academic impact, for papers by Funda Timurkaynak Breakdown of academic impact, for papers by L. Gualco Breakdown of academic impact, for papers by L. Stratchounski Breakdown of academic impact, for papers by S. Bouchillon Breakdown of academic impact, for papers by Mark E. Jones Breakdown of academic impact, for papers by Tetsuro Muratani Breakdown of academic impact, for papers by Hyuck Lee Breakdown of academic impact, for papers by Εlias Iosifidis
Rankless by CCL
2026